Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 21 | 2025 | 1001 | 2.190 |
Why?
|
| Exercise | 14 | 2022 | 692 | 1.830 |
Why?
|
| Cognition Disorders | 6 | 2017 | 243 | 1.460 |
Why?
|
| Cognition | 9 | 2023 | 473 | 1.430 |
Why?
|
| Aged | 49 | 2023 | 8214 | 1.330 |
Why?
|
| Ischemia | 3 | 2014 | 47 | 1.200 |
Why?
|
| Apolipoprotein E4 | 5 | 2016 | 67 | 0.970 |
Why?
|
| Lower Extremity | 3 | 2016 | 38 | 0.940 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2025 | 734 | 0.900 |
Why?
|
| Mortality | 5 | 2012 | 175 | 0.820 |
Why?
|
| Middle Aged | 38 | 2022 | 12222 | 0.780 |
Why?
|
| Male | 52 | 2025 | 23409 | 0.770 |
Why?
|
| Aged, 80 and over | 21 | 2018 | 2853 | 0.760 |
Why?
|
| Transportation of Patients | 1 | 2022 | 14 | 0.760 |
Why?
|
| Leisure Activities | 3 | 2012 | 41 | 0.750 |
Why?
|
| Health Status | 5 | 2012 | 442 | 0.720 |
Why?
|
| United States | 23 | 2017 | 5205 | 0.720 |
Why?
|
| Humans | 65 | 2025 | 43102 | 0.710 |
Why?
|
| Cholesterol, HDL | 3 | 2011 | 99 | 0.700 |
Why?
|
| Patient Participation | 1 | 2022 | 94 | 0.690 |
Why?
|
| Female | 47 | 2023 | 24698 | 0.670 |
Why?
|
| Vascular Surgical Procedures | 3 | 2016 | 18 | 0.660 |
Why?
|
| Nutrition Surveys | 6 | 2017 | 263 | 0.660 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 259 | 0.650 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2019 | 81 | 0.630 |
Why?
|
| Lipoproteins, LDL | 2 | 2019 | 67 | 0.630 |
Why?
|
| Cardiovascular Diseases | 4 | 2023 | 749 | 0.620 |
Why?
|
| Hypertension | 7 | 2009 | 835 | 0.620 |
Why?
|
| Limb Salvage | 3 | 2016 | 6 | 0.570 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 301 | 0.570 |
Why?
|
| Healthcare Disparities | 2 | 2014 | 590 | 0.570 |
Why?
|
| Patient Selection | 2 | 2017 | 205 | 0.560 |
Why?
|
| Apolipoproteins E | 5 | 2018 | 138 | 0.550 |
Why?
|
| Multivariate Analysis | 9 | 2016 | 638 | 0.540 |
Why?
|
| Genome-Wide Association Study | 7 | 2025 | 423 | 0.530 |
Why?
|
| Aging | 3 | 2011 | 783 | 0.510 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2014 | 20 | 0.510 |
Why?
|
| C-Reactive Protein | 3 | 2010 | 167 | 0.500 |
Why?
|
| Oxygen Consumption | 4 | 2015 | 110 | 0.490 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2015 | 6 | 0.460 |
Why?
|
| Muscle Stretching Exercises | 1 | 2015 | 3 | 0.460 |
Why?
|
| Blood Pressure | 7 | 2023 | 666 | 0.440 |
Why?
|
| Treatment Outcome | 8 | 2016 | 1604 | 0.440 |
Why?
|
| Religion | 3 | 2009 | 90 | 0.430 |
Why?
|
| Age Factors | 9 | 2016 | 1154 | 0.410 |
Why?
|
| Health Services Accessibility | 3 | 2022 | 706 | 0.400 |
Why?
|
| Risk Factors | 13 | 2017 | 3994 | 0.400 |
Why?
|
| Apolipoprotein E2 | 2 | 2012 | 6 | 0.390 |
Why?
|
| Upper Extremity | 1 | 2013 | 15 | 0.390 |
Why?
|
| Inpatients | 1 | 2013 | 78 | 0.390 |
Why?
|
| Activities of Daily Living | 2 | 2012 | 139 | 0.390 |
Why?
|
| Genotype | 11 | 2018 | 800 | 0.390 |
Why?
|
| Diabetes Complications | 1 | 2013 | 102 | 0.380 |
Why?
|
| Biomedical Research | 1 | 2017 | 502 | 0.370 |
Why?
|
| Vitamins | 1 | 2012 | 81 | 0.370 |
Why?
|
| Cause of Death | 2 | 2013 | 186 | 0.350 |
Why?
|
| Cotinine | 1 | 2011 | 44 | 0.350 |
Why?
|
| Coronary Disease | 1 | 2012 | 123 | 0.350 |
Why?
|
| Inflammation | 2 | 2023 | 758 | 0.340 |
Why?
|
| Cohort Studies | 9 | 2015 | 1759 | 0.330 |
Why?
|
| Follow-Up Studies | 6 | 2017 | 1067 | 0.330 |
Why?
|
| Exercise Therapy | 2 | 2016 | 87 | 0.330 |
Why?
|
| Self Concept | 1 | 2011 | 171 | 0.320 |
Why?
|
| Population Surveillance | 1 | 2011 | 246 | 0.310 |
Why?
|
| Memory | 2 | 2022 | 174 | 0.280 |
Why?
|
| Body Composition | 3 | 2010 | 159 | 0.280 |
Why?
|
| Minority Groups | 1 | 2013 | 690 | 0.280 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2011 | 989 | 0.270 |
Why?
|
| Interpersonal Relations | 1 | 2009 | 222 | 0.270 |
Why?
|
| Cross-Sectional Studies | 7 | 2023 | 3156 | 0.260 |
Why?
|
| Motor Activity | 1 | 2010 | 437 | 0.260 |
Why?
|
| Genetic Loci | 2 | 2025 | 104 | 0.260 |
Why?
|
| Stroke | 1 | 2011 | 340 | 0.260 |
Why?
|
| Databases, Factual | 5 | 2016 | 341 | 0.260 |
Why?
|
| Health Surveys | 4 | 2010 | 405 | 0.260 |
Why?
|
| Longitudinal Studies | 6 | 2011 | 1063 | 0.260 |
Why?
|
| Body Mass Index | 3 | 2006 | 925 | 0.250 |
Why?
|
| Genetic Counseling | 2 | 2017 | 15 | 0.250 |
Why?
|
| Time Factors | 6 | 2016 | 1857 | 0.240 |
Why?
|
| Statistics as Topic | 3 | 2015 | 123 | 0.240 |
Why?
|
| Primary Health Care | 1 | 2009 | 380 | 0.240 |
Why?
|
| Physical Education and Training | 1 | 2006 | 26 | 0.240 |
Why?
|
| Comorbidity | 5 | 2016 | 737 | 0.240 |
Why?
|
| Adult | 19 | 2017 | 13872 | 0.240 |
Why?
|
| Cerebral Infarction | 1 | 2006 | 19 | 0.240 |
Why?
|
| Religion and Medicine | 1 | 2006 | 20 | 0.240 |
Why?
|
| Disclosure | 2 | 2017 | 39 | 0.240 |
Why?
|
| Educational Status | 2 | 2022 | 339 | 0.240 |
Why?
|
| Hospitalization | 2 | 2013 | 485 | 0.230 |
Why?
|
| Health Status Disparities | 1 | 2012 | 719 | 0.230 |
Why?
|
| Pilot Projects | 2 | 2019 | 760 | 0.230 |
Why?
|
| Nutrition Assessment | 1 | 2006 | 80 | 0.230 |
Why?
|
| Food Preferences | 1 | 2006 | 73 | 0.230 |
Why?
|
| Anthropometry | 1 | 2005 | 97 | 0.220 |
Why?
|
| Smoking | 1 | 2011 | 1024 | 0.210 |
Why?
|
| Arteries | 2 | 2016 | 81 | 0.210 |
Why?
|
| Risk Assessment | 5 | 2017 | 863 | 0.210 |
Why?
|
| Genetic Testing | 2 | 2017 | 91 | 0.210 |
Why?
|
| Insulin Resistance | 1 | 2006 | 201 | 0.210 |
Why?
|
| Lipids | 1 | 2006 | 256 | 0.210 |
Why?
|
| Retrospective Studies | 6 | 2017 | 2544 | 0.210 |
Why?
|
| Critical Illness | 2 | 2014 | 47 | 0.210 |
Why?
|
| Hyperlipidemias | 1 | 2004 | 48 | 0.200 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2025 | 863 | 0.200 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 247 | 0.190 |
Why?
|
| Survival Rate | 3 | 2017 | 355 | 0.190 |
Why?
|
| Amyloid | 1 | 2023 | 65 | 0.190 |
Why?
|
| Genetic Variation | 4 | 2013 | 430 | 0.190 |
Why?
|
| Adolescent | 10 | 2014 | 6081 | 0.190 |
Why?
|
| Positron-Emission Tomography | 1 | 2023 | 93 | 0.190 |
Why?
|
| Dementia | 2 | 2014 | 160 | 0.190 |
Why?
|
| Heterozygote | 2 | 2016 | 110 | 0.180 |
Why?
|
| Young Adult | 8 | 2017 | 5080 | 0.180 |
Why?
|
| Mental Recall | 2 | 2012 | 84 | 0.180 |
Why?
|
| Homozygote | 2 | 2015 | 77 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 587 | 0.170 |
Why?
|
| Communication | 1 | 2022 | 210 | 0.160 |
Why?
|
| Postoperative Complications | 4 | 2016 | 263 | 0.160 |
Why?
|
| Chi-Square Distribution | 3 | 2016 | 236 | 0.150 |
Why?
|
| Triglycerides | 1 | 2019 | 147 | 0.150 |
Why?
|
| Proportional Hazards Models | 2 | 2011 | 518 | 0.150 |
Why?
|
| Heart Rate | 3 | 2018 | 266 | 0.150 |
Why?
|
| Incidence | 3 | 2014 | 1078 | 0.140 |
Why?
|
| Diabetes Mellitus | 1 | 2004 | 539 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2006 | 760 | 0.130 |
Why?
|
| Telephone | 1 | 2017 | 36 | 0.130 |
Why?
|
| Airway Obstruction | 1 | 2017 | 9 | 0.130 |
Why?
|
| Sex Factors | 3 | 2014 | 1028 | 0.130 |
Why?
|
| Plasma Exchange | 1 | 2017 | 4 | 0.130 |
Why?
|
| Albumins | 1 | 2017 | 33 | 0.130 |
Why?
|
| Forecasting | 1 | 2017 | 136 | 0.130 |
Why?
|
| Cerebrovascular Circulation | 1 | 2016 | 70 | 0.120 |
Why?
|
| Obesity | 2 | 2007 | 1151 | 0.120 |
Why?
|
| Brain | 2 | 2023 | 1472 | 0.120 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2015 | 82 | 0.120 |
Why?
|
| Odds Ratio | 3 | 2016 | 587 | 0.120 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 88 | 0.120 |
Why?
|
| Antihypertensive Agents | 2 | 2009 | 287 | 0.120 |
Why?
|
| Alleles | 1 | 2016 | 352 | 0.120 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2014 | 6 | 0.110 |
Why?
|
| Haplotypes | 2 | 2006 | 197 | 0.110 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2014 | 6 | 0.110 |
Why?
|
| Hippocampus | 1 | 2018 | 594 | 0.110 |
Why?
|
| Neuropsychological Tests | 3 | 2023 | 284 | 0.110 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 163 | 0.110 |
Why?
|
| Lung | 1 | 2017 | 492 | 0.100 |
Why?
|
| Survival Analysis | 2 | 2013 | 368 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2015 | 456 | 0.100 |
Why?
|
| Surgical Wound Infection | 1 | 2013 | 22 | 0.100 |
Why?
|
| Length of Stay | 1 | 2014 | 229 | 0.100 |
Why?
|
| Prevalence | 2 | 2010 | 1612 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2015 | 536 | 0.090 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2012 | 18 | 0.090 |
Why?
|
| Office Visits | 1 | 2011 | 28 | 0.090 |
Why?
|
| Geriatric Assessment | 1 | 2012 | 66 | 0.090 |
Why?
|
| Publishing | 1 | 2011 | 28 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 704 | 0.090 |
Why?
|
| Logistic Models | 2 | 2014 | 1009 | 0.080 |
Why?
|
| Survival | 1 | 2010 | 8 | 0.080 |
Why?
|
| Cats | 1 | 2010 | 82 | 0.080 |
Why?
|
| Cardiovascular Deconditioning | 1 | 2010 | 2 | 0.080 |
Why?
|
| Thrombin | 1 | 2010 | 28 | 0.080 |
Why?
|
| Physical Exertion | 1 | 2010 | 27 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2010 | 162 | 0.080 |
Why?
|
| Animals | 3 | 2016 | 16992 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 47 | 0.080 |
Why?
|
| Dogs | 1 | 2010 | 204 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2013 | 549 | 0.080 |
Why?
|
| Physical Fitness | 1 | 2010 | 90 | 0.080 |
Why?
|
| Health Care Surveys | 1 | 2009 | 152 | 0.080 |
Why?
|
| Case-Control Studies | 4 | 2015 | 1285 | 0.080 |
Why?
|
| Insurance Coverage | 1 | 2009 | 110 | 0.070 |
Why?
|
| Tobacco, Smokeless | 1 | 2009 | 19 | 0.070 |
Why?
|
| Sodium | 2 | 2007 | 102 | 0.070 |
Why?
|
| Stem Cells | 1 | 2010 | 152 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 107 | 0.070 |
Why?
|
| Apoptosis | 1 | 2016 | 1568 | 0.070 |
Why?
|
| Risk | 2 | 2013 | 287 | 0.070 |
Why?
|
| Health Services Needs and Demand | 1 | 2009 | 154 | 0.070 |
Why?
|
| Hospital Mortality | 3 | 2014 | 210 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 263 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 241 | 0.070 |
Why?
|
| Particle Size | 1 | 2008 | 272 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 375 | 0.070 |
Why?
|
| District of Columbia | 2 | 2005 | 80 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2010 | 329 | 0.060 |
Why?
|
| Aldosterone | 1 | 2007 | 66 | 0.060 |
Why?
|
| Angiotensinogen | 1 | 2006 | 6 | 0.060 |
Why?
|
| Area Under Curve | 1 | 2006 | 95 | 0.060 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2006 | 35 | 0.060 |
Why?
|
| Diet Records | 1 | 2006 | 58 | 0.060 |
Why?
|
| Gene Frequency | 1 | 2006 | 206 | 0.060 |
Why?
|
| Life Style | 1 | 2008 | 334 | 0.060 |
Why?
|
| Fishes | 1 | 2006 | 73 | 0.060 |
Why?
|
| Muscles | 1 | 2005 | 82 | 0.060 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2009 | 497 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 201 | 0.060 |
Why?
|
| Base Composition | 1 | 2004 | 26 | 0.050 |
Why?
|
| Thymine | 1 | 2004 | 25 | 0.050 |
Why?
|
| Adenine | 1 | 2004 | 46 | 0.050 |
Why?
|
| Guanine | 1 | 2004 | 44 | 0.050 |
Why?
|
| Point Mutation | 1 | 2004 | 98 | 0.050 |
Why?
|
| Insulin | 1 | 2006 | 258 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2006 | 389 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2010 | 1003 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 1234 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 1 | 2003 | 162 | 0.050 |
Why?
|
| Body Weight | 1 | 2005 | 429 | 0.050 |
Why?
|
| alpha-Synuclein | 1 | 2023 | 61 | 0.050 |
Why?
|
| Age of Onset | 2 | 2013 | 114 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2023 | 165 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 183 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2023 | 1600 | 0.040 |
Why?
|
| Anxiety | 2 | 2016 | 874 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2017 | 44 | 0.030 |
Why?
|
| Spirometry | 1 | 2017 | 40 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2017 | 2 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2017 | 75 | 0.030 |
Why?
|
| Reoperation | 1 | 2016 | 34 | 0.030 |
Why?
|
| Genes, Recessive | 1 | 2015 | 8 | 0.030 |
Why?
|
| Indiana | 1 | 2015 | 17 | 0.030 |
Why?
|
| Chicago | 1 | 2015 | 31 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2017 | 282 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2015 | 61 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 118 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2014 | 52 | 0.030 |
Why?
|
| Caribbean Region | 1 | 2014 | 79 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2014 | 259 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 86 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2013 | 128 | 0.020 |
Why?
|
| Apolipoprotein E3 | 1 | 2011 | 12 | 0.020 |
Why?
|
| Authorship | 1 | 2011 | 6 | 0.020 |
Why?
|
| Health Behavior | 1 | 2016 | 575 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 53 | 0.020 |
Why?
|
| Visual Cortex | 1 | 2012 | 64 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2012 | 183 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2012 | 137 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2012 | 199 | 0.020 |
Why?
|
| Forearm | 1 | 2010 | 5 | 0.020 |
Why?
|
| Sample Size | 1 | 2010 | 28 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2010 | 53 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 33 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 145 | 0.020 |
Why?
|
| Genomics | 1 | 2012 | 293 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2016 | 661 | 0.020 |
Why?
|
| Depression | 1 | 2016 | 863 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 575 | 0.020 |
Why?
|
| Spirituality | 1 | 2008 | 53 | 0.020 |
Why?
|
| Abdominal Fat | 1 | 2007 | 21 | 0.020 |
Why?
|
| Potassium | 1 | 2007 | 109 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2010 | 386 | 0.020 |
Why?
|
| Exercise Test | 1 | 2007 | 74 | 0.020 |
Why?
|
| Renin-Angiotensin System | 1 | 2006 | 48 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 1070 | 0.010 |
Why?
|
| Family Health | 1 | 2004 | 55 | 0.010 |
Why?
|
| Cardiovascular System | 1 | 2004 | 37 | 0.010 |
Why?
|
| Oxygen | 1 | 2004 | 218 | 0.010 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2002 | 1 | 0.010 |
Why?
|
| Cardiac Output | 1 | 2002 | 24 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 2002 | 36 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2002 | 122 | 0.010 |
Why?
|
| Parents | 1 | 2004 | 370 | 0.010 |
Why?
|